Below is a comprehensive archive of press releases from MSF-USA. Use the options in the boxes below to filter results based on your preferences.

August 31, 2017

Pharmaceutical company Chemo Group announced today that it will make a drug to treat the neglected tropical disease Chagas available to people in the United States. The U.S. Food and Drug Administration’s approval of the drug, benznidazole, means that Chagas pediatric patients in the U.S. could receive access to a therapy that Doctors Without Borders/Médecins Sans Frontières (MSF) has been using for decades to treat people living with Chagas across Latin America.

July 20, 2017

In anticipation of the rainy season—which coincides with the peak of malaria and increased malnutrition rates—Doctors Without Borders/Médecins Sans Frontières (MSF) is scaling up assistance to address what are expected to be increasing humanitarian and medical needs in hard-to-reach areas of Borno State, Nigeria.

December 20, 2016

NEW YORK, DECEMBER 20, 2016—After 14 years of Chagas diagnoses, treatment and prevention efforts in Bolivia, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) ended its Chagas operations today by presenting Bolivia’s Ministry of Health with an operating manual for managing Chagas disease in rural areas.

September 16, 2016

"The sustainable development goals (SDGs) adopted with much fanfare just a year ago seek to end HIV, tuberculosis, and malaria by 2030. The replenishment of the Global Fund is the first concrete action taken by the international community since the adoption of these goals, and therefore a first test of the world leaders' will to make them a reality. Failure to reach the relatively modest Global Fund's replenishment target would be a clear message that the SDGs were but empty promises to the millions who, every year, continue to suffer and die from HIV, tuberculosis, and malaria."

March 10, 2016

Judit Rius Sanjuan, Access Campaign manager & legal policy advisor at Doctors Without Borders/Médecins Sans Frontières (MSF), made the following statement after KaloBios Pharmaceuticals obtained bankruptcy court permission to keep pursing a drug that could receive a US Federal Drug Administration Priority Review Voucher (PRV).

January 25, 2016

Five diseases with the potential to become epidemics in 2016 are being highlighted by the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF), as the World Health Organization’s executive board meets in Geneva this week.

January 07, 2016

Doctors Without Borders retrospective study finds lower mortality risk among patients given a particular malaria medicine.

April 14, 2015

SUCRE, BOLIVIA/NEW YORKDoctors Without Borders/Médecins Sans Frontières (MSF) is launching a new project to ensure that people can be diagnosed and treated for Chagas disease in the town of Monteagudo, in the Chuquisaca department of southern Bolivia. In partnership with local health care institutions, the international medical humanitarian organization will develop a comprehensive care model for primary and secondary care that will be integrated into the existing health care system.

December 10, 2014

1.5 million people in Freetown and surrounding area to receive medicines.

November 06, 2014

A malaria epidemic in South Sudan has gone neglected due to the political crisis raging throughout the country, leading to insufficient distribution of antimalarial drugs in many peripheral health centers and an increase in the number of severe life-threatening cases of the disease.

Pages